Therapeutic approaches to reduce S100A4 expression, and thereby restrict cancer progression and metastasis, including RNA interference (RNAi) [15,16,17] and small molecules for intervention strategies in the Wnt pathway [18,19,20,21]. The gene discussed is S100A4; the disease is cancer.